Brown & Brown (BRO)
NYSEFinancialsInsurance BrokersSnapshot 2026-07-07
$69.28+1.24%
Close 2026-07-07 · 1-day change
Reading BRO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BRO free→NYSEFinancialsInsurance BrokersSnapshot 2026-07-07
Reading BRO? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BRO free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on maintaining operational efficiencies and enhancing earnings. The current thesis state is intact, supported by strong recent financial performance.
The valuation is considered expensive compared to peers, with a slight expectations gap. The market seems to have priced in a level of stability, as there are no significant fragility indicators present.
Management is making progress on key priorities, particularly in maintaining margins and enhancing earnings per share. However, organic revenue growth has shown mixed results in a challenging environment.
The thesis hinges on the company's ability to navigate potential risks, such as guidance cuts or changes in interest rates. Additionally, the performance of sector bellwethers will be crucial for maintaining momentum.
Overall, BRO's fundamentals appear solid for the next 1-3 years, but external factors could impact performance. Not investment advice.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. On one hand, BRO's latest earnings beat supports the view that its financial performance remains strong. On the other hand, concerns about softness in organic growth and a downgrade from Morgan Stanley indicate potential challenges ahead.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Keeping the EBITDAC Margin high is important for making money. It shows how well the company manages costs.
Confirms:EBITDAC Margin - Adjusted stays above 38.5% in Q2 2026.
Disproves:EBITDAC Margin - Adjusted falls below 38.5% in Q2 2026.
Why it matters: Growth in adjusted earnings per share shows the company can make more money. This is important for investors.
Confirms:Diluted Net Income Per Share - Adjusted increases more than 7.8% in Q2 2026.
Disproves:Diluted Net Income Per Share - Adjusted increases less than 7.8% or declines in Q2 2026.
Why it matters: Growth in Organic Revenue with Contingents is key for overall revenue health. It shows how well the company is performing in a tough market.
Confirms:Organic Revenue with Contingents increases more than 2.2% in Q2 2026.
Disproves:Organic Revenue with Contingents declines or grows less than 2.2% in Q2 2026.
Why it matters: The unemployment rate affects how much people spend and how much insurance they need. It is an important economic sign.
Confirms one read:Unemployment rate drops below 4.0% on July 9.
Confirms the other:Unemployment rate goes above 4.5% on July 9.
Why it matters: A drop in Organic Revenue may signal problems with the business model or market demand. This could hurt future growth.
Confirms:Organic Revenue decreases more than 2.8% in Q2 compared to Q1.
Disproves:Organic Revenue increases or stays above 2.8% in Q2.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.